3504.00.50
Other
Peptones and their derivatives; other protein substances and their derivatives, not elsewhere specified or included; hide powder, whether or not chromed
Data provenance: Rates from HTS Revision 16 (Aug 15, 2026); trade measures verified against CBP CSMS and Federal Register notices through Aug 15, 2026.
Duty rates
Column 1 (General / MFN)
4%
Column 2 (Non-NTR)
30.5%
Column 1 (Special / FTA)
Free
Eligible
The rates above are statutory column rates. Trade remedies in Chapter 99 (Section 301, 232, IEEPA, reciprocal) and FTA preferences can change the duty owed on a given entry — see below.
Trade measures (Chapter 99)
No active Chapter 99 measures are linked to this code.
Rate-change history
What the rate was before, and when it changed. The government schedule replaces each revision in place; we keep the timeline.
-
NEW_PROGRAM Executive Order Feb 1, 2026 — Reciprocal Tariff (FR 2026-03824)
Section 122 reciprocal surcharge in effect — additional 10% on most imports through July 24, 2026
See the change → -
Base rate (Rev. 2) HTS 2026
Column 1 general rate set to 4%.
Related CBP rulings
The tariff classification, country of origin, and marking of ioPea Protein
The tariff classification, country of origin, and marking of ioPea Protein
The classification, country of origin, and marking of pea protein isolate
The classification, country of origin, and marking of pea protein isolate
The tariff classification of LFX Synthetic Protein Isolate from China
The tariff classification of LFX Synthetic Protein Isolate from China
The tariff classification of Mori’s Silk Sheet (MSS) from an undisclosed country
The tariff classification of Mori’s Silk Sheet (MSS) from an undisclosed country
The tariff classification of Dry Mycoprotein from India
The subject product is described as shelf-stable, Dry Mycoprotein.
The tariff classification of Frozen Mycoprotein Paste from the United Kingdom
The subject product is described as Frozen Mycoprotein Paste (Item Code D09008).
The tariff classification of Mycoprotein Paste from the United Kingdom
You state that the frozen mycoprotein paste is a raw material, which will be imported in bulk for further processing and evaluation for use as an ingredient within meat alternative products. The subject product is derived from fungi, which
The tariff classification of Type II Collagen Powder (UC-II) from South Korea or other undisclosed countries
You identify the subject product as UC-II, which is described as an undenatured type II collagen.
The tariff classification of mycoprotein paste from the United Kingdom
The subject product is described as frozen mycoprotein paste, 3 x 5kg (Item Code A05025).
The tariff classification of “Bovine Collagen Gel and Powder” from Australia
” In your submission, you describe the product at issue as bovine collagen, derived from bovine hide-corium layer, which will be imported in gel and powder form in .5 kilogram and 50 gram pouches, respectively. You suggest classification in
The tariff classification of “Recombinant Human Vimentin Protein” from Israel
” In your submission, the product at issue is described as Vimentin Human Recombinant, produced in E.coli cells as a single non-glycosylated protein, containing 465 amino acids chain and having a molecular mass of 53.5kDa. You also indicate
The tariff classification of two varieties of “Pea Protein Powder” from China
” Your submitted samples have been reviewed and as you requested, will not be returned. In your submission, the products at issue are described as hydrolyzed pea protein powders, which will be imported from several Chinese suppliers. The fi
Other codes in heading 3504
Duty by origin country
The rate above is the statutory base. Total landed duty depends on origin — see the calculated rate for 3504.00.50 from each major US trading partner.
Follow 3504.00.50
Get an email when a new CBP ruling cites this code, a ruling on it is revoked, or its tariff measures change.
One email per day at most. Confirm your address once, unsubscribe anytime.
Need to defend this classification?
Get the full 10-digit classification with GRI reasoning for your product, backed by cited CBP rulings and an audit trail for reasonable care.